Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2011 1
2013 1
2014 2
2015 2
2017 3
2018 3
2019 3
2020 4
2021 5
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Prat A, Saura C, Pascual T, Hernando C, Muñoz M, Paré L, González Farré B, Fernández PL, Galván P, Chic N, González Farré X, Oliveira M, Gil-Gil M, Arumi M, Ferrer N, Montaño A, Izarzugaza Y, Llombart-Cussac A, Bratos R, González Santiago S, Martínez E, Hoyos S, Rojas B, Virizuela JA, Ortega V, López R, Céliz P, Ciruelos E, Villagrasa P, Gavilá J. Prat A, et al. Lancet Oncol. 2020 Jan;21(1):33-43. doi: 10.1016/S1470-2045(19)30786-7. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838010 Clinical Trial.
Hyperbaric oxygen and radiation therapy: a review.
Fernández E, Morillo V, Salvador M, Santafé A, Beato I, Rodríguez M, Ferrer C. Fernández E, et al. Clin Transl Oncol. 2021 Jun;23(6):1047-1053. doi: 10.1007/s12094-020-02513-5. Epub 2020 Nov 18. Clin Transl Oncol. 2021. PMID: 33206332 Review.
Pre-operative ribociclib plus letrozole versus chemotherapy: Health-related quality of life outcomes from the SOLTI CORALLEEN trial.
Villacampa G, Falato C, Paré L, Hernando C, Arumí M, Saura C, Gómez G, Muñoz M, Gil-Gil M, Izarzugaza Y, Ferrer N, Najera-Zuloaga J, Montaño A, Ciruelos E, González-Santiago S, Villagrasa P, Gavilá J, Prat A, Pascual T. Villacampa G, et al. Eur J Cancer. 2022 Oct;174:232-242. doi: 10.1016/j.ejca.2022.07.028. Epub 2022 Sep 5. Eur J Cancer. 2022. PMID: 36067616 Clinical Trial.
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.
Arrieta O, Cardona AF, Lara-Mejía L, Heredia D, Barrón F, Zatarain-Barrón ZL, Lozano F, de Lima VC, Maldonado F, Corona-Cruz F, Ramos M, Cabrera L, Martin C, Corrales L, Cuello M, Arroyo-Hernández M, Aman E, Bacon L, Baez R, Benitez S, Botero A, Burotto M, Caglevic C, Ferraris G, Freitas H, Kaen DL, Lamot S, Lyons G, Mas L, Mata A, Mathias C, Muñoz A, Patane AK, Oblitas G, Pino L, Raez LE, Remon J, Rojas L, Rolfo C, Ruiz-Patiño A, Samtani S, Viola L, Viteri S, Rosell R. Arrieta O, et al. Crit Rev Oncol Hematol. 2020 Sep;153:103033. doi: 10.1016/j.critrevonc.2020.103033. Epub 2020 Jun 20. Crit Rev Oncol Hematol. 2020. PMID: 32650215 Free PMC article. Review.
COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients.
Calle Rubio M, López-Campos JL, Miravitlles M, Michel de la Rosa FJ, Hernández Pérez JM, Montero Martínez C, Montoro Ronsano JB, Casas Maldonado F, Rodríguez Hermosa JL, Tabernero Huguet EM, Martínez Sesmero JM, Martínez Rivera C, Callejas González FJ, Torres Durán M. Calle Rubio M, et al. BMC Health Serv Res. 2023 Jan 30;23(1):98. doi: 10.1186/s12913-023-09094-3. BMC Health Serv Res. 2023. PMID: 36717880 Free PMC article.
Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?
Méndez R, González-Jiménez P, Latorre A, Mengot N, Zalacain R, Ruiz LA, Serrano L, España PP, Uranga A, Cillóniz C, Hervás D, Torres A, Menéndez R; NEUMONAC; RECOVID; Pablo España P, Borderías L, Rajas O, Almirall J, Zalacaín R, Vendrell M, Bello S, Mir I, Morales C, Molinos L, Ferrer R, Briones M, Malo R, Sayago Reza I, Almonte Batista W, Moreno Galarraga L, Sibila Vidal O, Luis Rodríguez Hermosa J, Vargas Centanaro G, de Vega Sánchez B, Solís García E, Rodríguez Florez E, José M, Estaba C, Molina Molina M, Bordas J, Estela González Castro M, Badenes Bonet D, Domínguez Álvarez M, Pérez-Rodas EN, Marín Arguedas A, Román Bernal B, Estrada Trigueros G, Cuenca Peris S, Martín Royo M, Torres García M, Portillo Sánchez J, Lerenas Bernal F, Salome Ros Braquehais M, Alfonso García Guerra J, Dolores Martínez Pitarch M, Arroyo Fernández I, Guevara Velázquez V, Martínez Olondris P, Francisco Pereyra Barrionuevo M, Lázaro Sierra J, Clavería P, Luis Wangüemert Pérez A, Joel Ruiz Lacambra J, Fernández Ramos N, Guanche Dorta S, Macias Paredes A, de la Rosa Carrillo D, Palones Femenia E, Podzamczer Valls I, Peñacoba Toribio P, Muñoz Zara P, García García R, Del Mar Marrube Fernández M, Villar Ag… See abstract for full author list ➔ Méndez R, et al. Front Med (Lausanne). 2023 Oct 10;10:1236142. doi: 10.3389/fmed.2023.1236142. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37886363 Free PMC article.
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Alvarez-Larrán A, Garrote M, Ferrer-Marín F, Pérez-Encinas M, Mata-Vazquez MI, Bellosillo B, Arellano-Rodrigo E, Gómez M, García R, García-Gutiérrez V, Gasior M, Cuevas B, Angona A, Gómez-Casares MT, Martínez CM, Magro E, Ayala R, Del Orbe-Barreto R, Pérez-López R, Fox ML, Raya JM, Guerrero L, García-Hernández C, Caballero G, Murillo I, Xicoy B, Ramírez MJ, Carreño-Tarragona G, Hernández-Boluda JC, Pereira A; MPN Spanish Group (Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas). Alvarez-Larrán A, et al. Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417564 Free PMC article.
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Rodríguez A, Arenas M, Lara PC, López-Torrecilla J, Algara M, Conde A, Pérez-Montero H, Muñoz JL, Peleteiro P, Pérez-Calatayud MJ, Contreras J, Ferrer C; Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group. Rodríguez A, et al. Clin Transl Oncol. 2019 Dec;21(12):1663-1672. doi: 10.1007/s12094-019-02095-x. Epub 2019 Apr 3. Clin Transl Oncol. 2019. PMID: 30941701
31 results